The present invention relates to a pharmaceutical combination comprising: (a)a PPAR agonist; (b) a p 38 kinase inhibitor;and optionally (c) one or more pharmaceutically acceptable diluents,excipients or carriers for use in a method of preventing or treatingophthalmic diseases or disorders in a subject.